RESEARCHER PROFILE

Ron A. A. Mathôt

← Back to Amsterdam UMC Location University of Amsterdam

R

Amsterdam UMC Location University of Amsterdam

Pharmaceutical studies and practicesPharmacogenetics and Drug MetabolismAntibiotics Pharmacokinetics and EfficacyHemophilia Treatment and ResearchPlatelet Disorders and Treatments

Ron A. A. Mathôt works in Pharmaceutical studies and practices, Pharmacogenetics and Drug Metabolism, Antibiotics Pharmacokinetics and Efficacy, Hemophilia Treatment and Research, Platelet Disorders and Treatments. Recorded institutional associations include Amsterdam UMC Location University of Amsterdam, Amsterdam University Medical Centers, Vrije Universiteit Amsterdam.

499Publications
12,112Citations
54H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. 36th International Symposium on Intensive Care and Emergency Medicine

    2016 · 526 citations
  2. Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

    2015 · 433 citations
  3. Metformin in patients with advanced pancreatic cancer: a double-blind, randomised, placebo-controlled phase 2 trial

    2015 · 384 citations
  4. Cyclosporine Interacts with Mycophenolic Acid by Inhibiting the Multidrug Resistance-Associated Protein 2

    2005 · 300 citations
  5. High within-patient variability in the clearance of tacrolimus is a risk factor for poor long-term outcome after kidney transplantation

    2010 · 256 citations
  6. Determinants of drug absorption in different ECMO circuits

    2010 · 254 citations
  7. Impact of Goal-Oriented and Model-Based Clinical Pharmacokinetic Dosing of Aminoglycosides on Clinical Outcome: A Cost-Effectiveness Analysis

    1999 · 244 citations
  8. Effect of Intravenous Paracetamol on Postoperative Morphine Requirements in Neonates and Infants Undergoing Major Noncardiac Surgery

    2013 · 236 citations
  9. Alternative drug formulations of docetaxel: a review

    2006 · 211 citations
  10. Pharmacokinetic Features and Presence of Antidrug Antibodies Associate With Response to Infliximab Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis

    2015 · 201 citations
  11. Explaining Variability in Mycophenolic Acid Exposure to Optimize Mycophenolate Mofetil Dosing

    2006 · 191 citations
  12. Drug interaction between St John's wort and nevirapine

    2001 · 177 citations
  13. Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the and genes

    2004 · 172 citations
  14. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis

    2018 · 140 citations
  15. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s Disease

    2019 · 132 citations
  16. Suppression of anti‐drug antibodies to infliximab or adalimumab with the addition of an immunomodulator in patients with inflammatory bowel disease

    2017 · 124 citations
  17. Efficacy of dashboard driven dosing of infliximab in inflammatory bowel disease patients; a randomized controlled trial

    2020 · 118 citations
  18. Potential for improvement of docetaxel-based chemotherapy: a pharmacological review

    2005 · 111 citations
  19. Medication use during end-of-life care in a palliative care centre

    2015 · 109 citations
  20. Population Pharmacokinetics of Mycophenolic Acid in Renal Transplant Recipients

    2005 · 100 citations
  21. A simple quantitative method analysing amikacin, gentamicin, and vancomycin levels in human newborn plasma using ion-pair liquid chromatography/tandem mass spectrometry and its applicability to a clinical study

    2014 · 89 citations
  22. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients

    2009 · 88 citations
  23. Yondelis® (trabectedin, ET-743): the development of an anticancer agent of marine origin

    2003 · 88 citations
  24. Clinical Pharmacokinetics of Gentamicin in Various Patient Populations and Consequences for Optimal Dosing for Gram-Negative Infections: An Updated Review

    2022 · 88 citations
  25. Effect of CYP2C19 *2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians

    2008 · 85 citations

← Return to the university profile